Veloxis Pharmaceuticals A/S establishes new Warrant

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Veloxis Pharmaceuticals A/S establishes new Warrant Programme

Company Announcement no. 19/2014

To: NASDAQ OMX Copenhagen A/S                             Hørsholm, Denmark, 20 august 2014

Veloxis Pharmaceuticals A/S establishes new Warrant Programme

Today, the Board of Directors of Veloxis has decided to establish a new warrant programme for new employees of the company and members of the board of directors. Thus, the Board of Directors of the Company has today partly exercised its authorisation pursuant to Section 5A of the Articles of Association.

The purpose of the grant of warrants is to reflect the company's objective to attract and retain first-rate employees and thus ensure a long-term shareholder value creation. The grant of warrants shall ensure to create - both in the short and in the long run - common interests between the employees and the shareholders of the Company.

A total of 2,255,000 warrants are to be awarded, giving the right to subscription of up to 2,255,000 shares each of DKK 0.1. The exercise price is fixed at DKK 1.86.

The warrant holders earn the right to exercise warrants with 1/36 per month as from the date of grant 20 august 2014. Warrants that are not exercised on 20 august 2021 expire automatically.

The issued warrants are estimated to have a total market value of DKK 1,707,176. The market value of the issued warrants is calculated on basis of the Black-Scholes model with a volatility calculated as 51%, an interest level of 0.37% and a share price of DKK 1.86.
 

For more information, please contact:

Veloxis Pharmaceuticals A/S

Bill Polvino                                           Johnny Stilou

President & CEO                                   EVP, Chief Financial Officer

Mobile: +1 917 647 9107                      Mobile: +45 21 227 227

Email: wjp@veloxis.com                       Email: jst@veloxis.com

For further information, please visit www.veloxis.com .

About Veloxis Pharmaceuticals

Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. The company’s lead product candidate is Envarsus® XR for immunosuppression, specifically organ transplantation. Veloxis’ unique, patented delivery technology, MeltDose®, can improve absorption and bioavailability at low scale up costs.  Veloxis has a lipid lowering product, Fenoglide®, currently on the U.S. market that is commercialized through partner Salix, Inc. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.

For further information, please visit www.veloxis.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 6

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 9

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 3

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 6

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco-Growth Strategies Enhances Investor Relations Program

Updated Category News Views 122

Enhancing Investor Engagement and Communication Company Reaffirms Commitment to Transparent Communications Eco-Growth Strategies, Inc. (OTC: ECGS), a prominent entity in the bottled water industry, has taken significant steps to improve its investor relations services. The company has recently enlisted the expertise of TraDigital Marketing Group, an influencer in investor...

Continue Reading
Walgreens Class Action Suit: Stakeholder Implications and Analysis

Updated Category News Views 176

Understanding the Class Action Against Walgreens Boots Alliance Pomerantz LLP has recently initiated a class action lawsuit against Walgreens Boots Alliance, Inc. (NASDAQ: WBA) and certain of its executives. This lawsuit represents the interests of all individuals and entities who acquired Walgreens common stock during a specified class period. The aim is to address...

Continue Reading
Public Restroom Access Across the United States: A Thorough Review

Updated Category News Views 349

Public Restroom Accessibility in the U.S. Access to public restrooms is a significant concern for travelers and residents alike. TENA, a prominent brand in incontinence care, has undertaken a comprehensive ranking of U.S. states and cities. This evaluation focuses on several key factors, including visibility on popular mapping services, restroom density relative to the...

Continue Reading
Legal Action Updates for AstraZeneca Investors Amid Losses

Updated Category News Views 135

AstraZeneca Investors Alerted About Class Action Lawsuit Lowey Dannenberg P.C., a leading law firm dedicated to protecting consumer and investor rights, has taken action against AstraZeneca PLC (NASDAQ: AZN). They recently filed a class action lawsuit due to significant concerns regarding AstraZeneca's alleged misconduct and misleading practices throughout a specified...

Continue Reading
Tri-County Financial Group, Inc. Reveals Solid Quarters Results

Updated Category News Views 77

Tri-County Financial Group, Inc. Financial Performance Overview Tri-County Financial Group, Inc. (TYFG) recently released its financial results for the third quarter, showcasing substantial earnings and a strong economic outlook. Income and Earnings Analysis The reported net income for the third quarter totaled $3.1 million, which equates to $1.27 per share. This marked a...

Continue Reading